AMFI - Registered Mutual Fund Distributor

Corona Remedies Limited IPO

Corona Remedies Limited IPO

₹ 14868 / 14 Shares Shares
Minimum Investment

Corona Remedies Limited IPO

Issues Price

₹1008-1062 per equity share

Corona Remedies Limited IPO

Open Date

08 Dec 2025

Close Date

10 Dec 2025

Lot Size

14

Min. Investment

₹ 14868

Issue Price

₹1008-1062

Listing Date

15 Dec 2025

Issues Size

61,71,101 shares(aggregating up to ₹655.37 crore)

Face Value

₹10 Per Equity Share

Total Shares Offered

14 Shares

Offered To Public

14 Shares

Corona Remedies Limited IPO

Incorporated in August 2004, Corona Remedies Limited is a pharmaceutical company developing, manufacturing, and marketing products in women's healthcare, cardiology, pain management, urology, and other therapeutic areas. The diversified portfolio of the company as of December 2024 comprises 67 brands across therapeutic areas such as women's healthcare, cardio-diabeto, pain management, urology, and multispecialty pharmaceuticals, including vitamins/minerals/nutrition, gastrointestinal, and respiratory.The company has a pan-India marketing and distribution network with 2,598 medical representatives in 22 states, enabling effective engagement with healthcare professionals and hospitals, thus consolidating its presence in the IPM and ensuring deep penetration in therapeutic areas. Presently, the company owns two manufacturing facilities located in the states of Gujarat. As of December 31, 2024, the company had 88 R&D employees.

Founded In

2004

Managing Director

Dr. Kirtikumar Laxmidas Mehta

Parent Organization

Corona Remedies Limited IPO

Application Details of Corona Remedies Limited IPO.

Apply as Price Range Apply Upto
Retail (min) ₹1008-1062 ₹14,868
Retail(max) ₹1008-1062 ₹1,93,284
SHNI(min) ₹1008-1062 ₹2,08,152
SHNI(max) ₹1008-1062 ₹9,96,156
BHNI(min) ₹1008-1062 ₹10,11,024

For Corona Remedies Limited IPO, eligible investors can apply as Regular.

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹2061-2165

ksquare

Open On15 Dec 2025

Close On17 Dec 2025

Price Range₹126

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹135-142

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹94-96

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹112-118

ksquare

Open On10 Dec 2025

Close On12 Dec 2025

Price Range₹12


Testimonial

Genuine Review Form Statisifed Customers

4.8 Out of 5 (3571 Reviews)

The way KSquare introduces New Fund Offerings is so clear and informative. I’ve been able to diversify with great timing and zero confusion.

Vikrant Kulkarni

Vikrant Kulkarni

IT Manager

KSquare made it easy to access funds against my mutual investments. The process was fast, smooth, and completely transparent.

Varun Malhotra

Varun Malhotra

Investment Banker

I had doubts about NPS before. KSquare explained every detail, making my decision easy. Their support and transparency are unmatched.

Sneha Tiwari

Sneha Tiwari

Financial Analyst

The NFO section on KSquare is so well designed. I love the simplified jargon and timely alerts before each launch. Great for busy professionals!

Prachi Wadhwa

Prachi Wadhwa

Veterinarian

I started my NPS with KSquare last year, and the process was very smooth. I trust them with long-term goals.

Deepika Menon

Deepika Menon

Digital Marketer

The fund selection process at KSquare is simple yet thorough. Their insights helped me diversify properly and reduce risk effectively. Very pleased!

Abhinav Kohli

Abhinav Kohli

Petroleum Engineer

I was impressed by how seamless KSquare’s NRI services are. They handled my documentation with care and helped me invest without unnecessary hassle.

Amit Sethi

Amit Sethi

Banking Professional

KSquare made investing so simple! Their SIP options fit my monthly budget and help me build wealth consistently without worry. I highly recommend it to anyone starting their financial journey.

Aarav Sharma

Aarav Sharma

Software Engineer

Thanks to KSquare, I purchased my first car without loans. The SIP plan was perfectly calculated and aligned with my budget, making everything financially smooth and stress-free.

Harsh Mehta

Harsh Mehta

Thanks to KSquare, my retirement plan feels organized. Their NPS tools and knowledge gave me real confidence in the future.

Tanya Khosla

Tanya Khosla

PR Consultant

FAQ's

Frequenlty Asked Question

Can I invest jointly with a resident Indian through KSquare?

Yes, joint investments are allowed with a resident Indian, provided KYC and bank account norms are met.

Is there a processing fee for LAMF through KSquare?

A nominal processing fee may apply depending on the lender. KSquare clearly discloses all charges upfront.

Is there a lock-in period for New Fund Offerings?

Open-ended NFOs usually have no lock-in, while close-ended ones might restrict withdrawals for a specific term.

What happens if I stop my SIP before maturity?

You can withdraw your invested amount anytime. However, early exits might impact your long-term growth potential.

How do I manage taxes on my investments as an NRI?

KSquare provides tax guidance specific to NRIs, helping you plan and stay compliant with Indian tax laws.

Do I need a demat account to apply for this loan?

Yes, most lenders require mutual fund units in demat form. KSquare can help convert physical units if needed.

Do SIPs guarantee returns?

No, SIPs don’t guarantee returns but reduce risk over time and provide the potential for solid, market-linked growth.

When do NFO units get credited to my account?

Units are credited within a few days after the NFO closes and the scheme is processed by the fund house.

App Store